Parungao, Liliosa B.
HRN: 27-35-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
CEFTRIAXONE 1G (VIAL)
06/19/2025
06/25/2025
IV
2g
OD
Cap Mr
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: